FoetoH, Best Emerging Medtech
Award Presented by Team Consulting
FoetoH is a new portable technology for the care of babies before they are born. FoetoH targets foetal health and helps prevent stillbirths by providing a better quality and frequency of foetal monitoring anytime, anywhere and by anyone.
PsiOxus Therapeutics, Best Biotech Fundraiser
Award Presented by Pivotal Scientific
In July 2012, PsiOxus Therapeutics announced its closing of a Series B round of equity financing totalling £22 million, including investments from investors Imperial Innovations Invesco Perpetual, SR One and Lundbeckfond Ventures. The financing round will enable PsiOxus to advance the clinical development of ColoAd1, a systemically available oncolytic vaccine for the treatment of colorectal cancer.
Oxford Nanopore Technologies, Best Medtech Fundraiser
Award Presented by Milton Park
Oxford Nanopore is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores. The modular, scalable technology platform and miniaturised instrument are designed to offer substantial benefits in a variety of applications including DNA and protein sequencing. In May 2012, Oxford Nanopore announced a further fundraising of £31.4 million making them the largest disclosed fundraiser in the cluster this year.
EUSA Pharma, Best Biotech Dealmaker
Award Presented by Manches
In June 2012, EUSA Pharma was acquired by Jazz Pharmaceuticals for $680 million. The acquisition brings a portfolio of seven products including a significant new specialty product to the Jazz Pharmaceuticals U.S. portfolio including Erwinaze™ (asparaginase Erwiniachrysanthemi), a life-saving treatment for patients with acute ly
Copyright©2012 PR Newswire.
All rights reserved